2013;173:132 9. 727. Bassand JP, Hamm CW, Ardissino D, et al. Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. Eur Heart J. 2007;28:1598 660. 728. Oliveira GB, Crespo EM, Becker RC, et al. Incidence and prognostic sig- nificance of thrombocytopenia in patients treated with prolonged heparin therapy. Arch Intern Med. 2008;168:94 102. 729. Wang TY, Ou FS, Roe MT, et al. Incidence and prognostic significance of thrombocytopenia developed during acute coronary syndrome in con- temporary clinical practice. Circulation. 2009;119:2454 62. 730. Hakim DA, Dangas GD, CaixetaA, et al. Impact of baseline thrombocyto- penia on the early and late outcomes after ST-elevation myocardial infarc- tion treated with primary angioplasty: analysis from the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) trial. Am Heart J. 2011;161:391 6. 731. McClure MW, Berkowitz SD, Sparapani R, et al. Clinical significance of thrombocytopenia during a non-ST-elevation acute coronary syndrome. The platelet glycoprotein IIb/IIIa in unstable angina: receptor suppres- sion using integrilin therapy (PURSUIT) trial experience. Circulation. 1999;99:2892 900. 732. Dasgupta H, Blankenship JC, Wood GC, et al. Thrombocytopenia com- plicating treatment with intravenous glycoprotein IIb/IIIa receptor inhib- itors: a pooled analysis. Am Heart J. 2000;140:206 11. 733. Matthai WH Jr. Evaluation of thrombocytopenia in the acute coronary syndrome. Curr Opin Hematol. 2010;17:398 404. 734. Kilickiran AB, Oto A, Ozcebe O. Thrombocytopenia associated with antithrombotic therapy in patients with cardiovascular diseases: diagno- sis and treatment. Am J Cardiovasc Drugs. 2008;8:327 39. 735. Gore JM, Spencer FA, Gurfinkel EP, et al. Thrombocytopenia in patients with an acute coronary syndrome (from the Global Registry of Acute Coronary Events [GRACE]). Am J Cardiol. 2009;103:175 80. 736. Yeh RW, Wiviott SD, Giugliano RP, et al. 